| 2023-11-08 |
复牌提示：
2023-11-07 19:50:00 停牌，复牌日期 2023-11-09 00:00:01
|
| 2023-11-06 |
详情>>
股本变动：
变动后总股本4182.60万股
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.98美元,归母净利润-4078.7万美元,同比去年增长-116.81%
|
| 2023-08-02 |
详情>>
业绩披露：
2023年中报每股收益-0.91美元,归母净利润-3799.7万美元,同比去年增长-53.14%
|
| 2023-08-02 |
财报披露：
美东时间 2023-08-02 盘前发布财报
|
| 2023-05-01 |
股东大会：
将于2023-05-24召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following eleven nominees to serve on our Board of Directors (the “Board”) until our 2024 Annual Meeting or until their respective successors are duly elected and qualified:1A. Paolo Fundarò;1B. Jerome Durso;1C. Srinivas Akkaraju, M.D., Ph.D.;1D. Luca Benatti, Ph.D.;1E. Daniel Bradbury;1F. Keith Gottesdiener, M.D.;1G. Nancy Miller-Rich;1H. Mark Pruzanski, M.D.;1I. Dagmar Rosa-Bjorkeson;1J. Gino Santini;1K. Glenn Sblendorio.
2.To approve our 2023 equity incentive plan.
3.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.
4.To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023.
5.To transact such other business as may properly come before the meeting or any adjournments thereof.
|
| 2023-04-27 |
详情>>
业绩披露：
2023年一季报每股收益-0.77美元,归母净利润-3213.5万美元,同比去年增长-85.92%
|
| 2023-03-02 |
详情>>
业绩披露：
2020年年报每股收益-8.34美元,归母净利润-2.75亿美元,同比去年增长20.25%
|
| 2023-03-02 |
详情>>
业绩披露：
2022年年报每股收益6.56美元,归母净利润2.22亿美元,同比去年增长342.62%
|
| 2022-11-01 |
详情>>
业绩披露：
2022年三季报(累计)每股收益7.76美元,归母净利润2.43亿美元,同比去年增长540.00%
|
| 2022-08-03 |
详情>>
业绩披露：
2022年中报每股收益-0.83美元,归母净利润-2481.2万美元,同比去年增长51.83%
|
| 2022-08-03 |
详情>>
业绩披露：
2021年中报每股收益-1.55美元,归母净利润-5151.4万美元,同比去年增长67.03%
|
| 2022-05-06 |
详情>>
业绩披露：
2022年一季报每股收益-0.58美元,归母净利润-1728.4万美元,同比去年增长57.24%
|
| 2022-05-02 |
股东大会：
将于2022-05-25召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following eleven nominees to serve on our Board of Directors (the “Board”) until our 2023 Annual Meeting or until their respective successors are duly elected and qualified
2.To approve our amended and restated equity incentive plan.
3.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.
4.To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2022.
5.To transact such other business as may properly come before the meeting or any adjournments thereof.
|
| 2022-03-02 |
详情>>
业绩披露：
2021年年报每股收益-2.87美元,归母净利润-9142.6万美元,同比去年增长66.74%
|
| 2021-11-03 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-1.69美元,归母净利润-5514.6万美元,同比去年增长75.24%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-27 |
股东大会：
将于2021-05-27召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following eleven nominees to serve on the Board of Directors until the 2022 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified:1A. Paolo Fundarò; 1B. Mark Pruzanski, M.D.; 1C. Srinivas Akkaraju, M.D., Ph.D.; 1D. Luca Benatti, Ph.D.; 1E.Daniel Bradbury; 1F Keith Gottesdiener, M.D.; 1G. Nancy Miller-Rich; 1H. Gino Santini; 1I. Glenn Sblendorio; 1J. Daniel Welch.
2.To approve a one-time stock option exchange program for non-executive employees.
3.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.
4.To vote, on a non-binding, advisory basis, as to whether the stockholder advisory vote to approve the compensation of the Company’s named executive officers (i.e., Proposal 3), should occur every one, two, or three years.
5.To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2021.
6.To transact such other business as may properly come before the meeting or any adjournments thereof.
|
| 2020-04-29 |
股东大会：
将于2020-05-28召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following ten nominees to serve on the Board of Directors until the 2021 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified:1A. Paolo Fundarò; 1B. Mark Pruzanski, M.D.; 1C. Srinivas Akkaraju, M.D., Ph.D.; 1D. Luca Benatti, Ph.D.; 1E.
Daniel Bradbury; 1F Keith Gottesdiener, M.D.; 1G. Nancy Miller-Rich; 1H. Gino Santini; 1I. Glenn Sblendorio; 1J. Daniel Welch.
2.To approve an amendment to the Company’s Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 45,000,000 to 90,000,000.
3.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.
4.To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2020.
5.To transact such other business as may properly come before the meeting or any adjournments thereof.
|
| 2019-04-30 |
股东大会：
将于2019-06-20召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following ten nominees to serve on the Board of Directors until the 2020 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified:
1A. Paolo Fundarò;1B. Mark Pruzanski, M.D.;1C. Srinivas Akkaraju, M.D., Ph.D.;
1D. Luca Benatti, Ph.D.;1E. Daniel Bradbury;1F. Keith Gottesdiener, M.D.;1G. Nancy Miller-Rich;1H. Gino Santini;1I. Glenn Sblendorio; and 1J. Daniel Welch.
2.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.
3.To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2019.
4.To transact such other business as may properly come before the meeting or any adjournments thereof.
|
| 2018-09-05 |
详情>>
内部人交易：
Shapiro David股份减少4917.00股
|
| 2018-04-27 |
股东大会：
将于2018-06-20召开股东大会
会议内容 ▼▲
- 1.To elect, by separate resolutions, the following ten nominees to serve on the Board of Directors until the 2019 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified:
1A. Paolo Fundarò; 1B. Mark Pruzanski, M.D.; 1C. Srinivas Akkaraju, M.D., Ph.D.;
1D. Luca Benatti, Ph.D.; 1E. Daniel Bradbury; 1F. Keith Gottesdiener, M.D.;
1G. Nancy Miller-Rich; 1H. Gino Santini; 1I. Glenn Sblendorio; and 1J. Daniel Welch.
2.To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers.
3.To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2018.
4.To transact such other business as may properly come before the meeting or any adjournments thereof.
|
| 2017-05-01 |
股东大会：
将于2017-06-27召开股东大会
会议内容 ▼▲
- 1. To elect nine directors, to serve one-year terms, expiring at the next annual meeting of stockholders in 2018;
2. To approve, on a non-binding advisory basis, the compensation of our named executive officers;
3. To ratify the appointment of KPMG LLP as Intercept’s independent registered public accounting firm for the fiscal year ending December 31, 2017;
4. To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2016-06-20 |
股东大会：
将于2016-07-19召开股东大会
会议内容 ▼▲
- 1. To elect nine directors, to serve one-year terms, expiring at the next annual meeting of stockholders in 2017;
2. To amend Intercept’s certificate of incorporation to increase the number of authorized shares of common stock from 35,000,000 shares to 45,000,000 shares;
3. To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4. To ratify the appointment of KPMG LLP as Intercept’s independent registered public accounting firm for the fiscal year ending December 31, 2016;
5. To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2015-10-29 |
股东大会：
将于2015-11-24召开股东大会
会议内容 ▼▲
- 1.To elect nine directors, to serve one-year terms, expiring at the next annual meeting of stockholders in 2016;
2.To approve on a non-binding advisory basis, the compensation of our named executive officers;
3.To vote, on a non-binding advisory basis, on the frequency of future stockholder advisory votes on executive compensation;
4.To ratify the appointment of KPMG LLP as Intercept’s independent registered public accounting firm for the fiscal year ending December 31, 2015;
5.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2014-06-23 |
股东大会：
将于2014-07-17召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to serve one-year terms expiring at the next annual meeting of stockholders in 2015;
2.To amend Intercept’s certificate of incorporation to increase the number of authorized shares of common stock from 25,000,000 shares to 35,000,000 shares;
3.To ratify the appointment of KPMG LLP as Intercept’s independent registered public accounting firm for the fiscal year ending December 31, 2014;
4.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|